{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:16:49Z","timestamp":1777083409609,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020483","name":"Insmed Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002077","name":"Epidermolysis Bullosa Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.rmed.2025.108052","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T12:53:08Z","timestamp":1742734388000},"page":"108052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Relationship between culture conversion and clinical outcomes in nontuberculous mycobacterial pulmonary disease: Narrative review"],"prefix":"10.1016","volume":"241","author":[{"given":"Kevin L.","family":"Winthrop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M.","family":"Mingora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-4489","authenticated-orcid":false,"given":"Cara D.","family":"Varley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Dorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick A.","family":"Flume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.rmed.2025.108052_bib1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2025.108052_bib3","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/17476348.2021.1987891","article-title":"Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments","volume":"15","author":"van Ingen","year":"2021","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/ijmy.ijmy_3_20","article-title":"Outcomes of pulmonary Mycobacterium abscessus infection","volume":"9","author":"Flight","year":"2020","journal-title":"Int J Mycobacteriol"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4046\/trd.2018.0060","article-title":"Treatment of Mycobacterium avium complex pulmonary disease","volume":"82","author":"Kwon","year":"2019","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"issue":"Supplement 2","key":"10.1016\/j.rmed.2025.108052_bib6","first-page":"26","article-title":"Challenges in the diagnose and treatment of nontuberculosis mycobacteria pulmonary disease (NTM-PD)","volume":"24","author":"Nguyen","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2025.108052_bib7","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jfma.2020.05.028","article-title":"Treatment for Mycobacterium abscessus complex\u2013lung disease","volume":"119","author":"Weng","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"issue":"2","key":"10.1016\/j.rmed.2025.108052_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.chest.2020.08.2055","article-title":"Development of drugs for nontuberculous mycobacterial disease: clinicians' interpretation of a US Food and Drug Administration workshop","volume":"159","author":"Flume","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.resinv.2018.08.006","article-title":"Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease","volume":"57","author":"Hagiwara","year":"2019","journal-title":"Respir Investig"},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02503-2016","article-title":"Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype","volume":"50","author":"Koh","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.108052_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2017.04.175","article-title":"Safety and effectiveness of clofazimine for primary and refractory nontuberculous mycobacterial infection","volume":"152","author":"Martiniano","year":"2017","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2025.108052_bib12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/cid\/cix479","article-title":"Microbiological persistence in patients with Mycobacterium avium complex lung disease: the predictors and the impact on radiographic progression","volume":"65","author":"Pan","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2025.108052_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijid.2020.06.019","article-title":"Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility","volume":"98","author":"Chang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2025.108052_bib14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.chest.2018.01.024","article-title":"Microbiologic outcome of interventions against Mycobacterium avium complex pulmonary disease: a systematic review","volume":"153","author":"Diel","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"van Ingen","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108052_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1164\/rccm.201503-0444OC","article-title":"Semiquantitative culture analysis during therapy for Mycobacterium avium complex lung disease","volume":"192","author":"Griffith","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108052_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1378\/chest.107.4.1035","article-title":"Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS","volume":"107","author":"Dautzenberg","year":"1995","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3904\/kjim.2011.26.1.54","article-title":"Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease","volume":"26","author":"Kim","year":"2011","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09031936.00074207","article-title":"Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings","volume":"32","author":"Kuroishi","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2025.108052_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1086\/313644","article-title":"Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex","volume":"30","author":"Griffith","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.rmed.2025.108052_bib21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320512","article-title":"Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease","volume":"32","author":"Griffith","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2025.108052_bib22","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268821000960","article-title":"Exacerbating factors in elderly patients with Mycobacterium avium complex pulmonary disease","volume":"149","author":"Kodaka","year":"2021","journal-title":"Epidemiol. Infect."},{"issue":"9","key":"10.1016\/j.rmed.2025.108052_bib23","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.3390\/jcm9092968","article-title":"Outcomes of inhaled amikacin and clofazimine-containing regimens for treatment of refractory Mycobacterium avium complex pulmonary disease","volume":"9","author":"Kim","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108052_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2019.08.1029","article-title":"The relationship between culture conversion and improvement in 6-minute walk test distance in the CONVERT study evaluating amikacin liposome inhalation suspension for refractory Mycobacterium avium complex (MAC) lung disease","volume":"156","author":"Mange","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2025.108052_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/PROM.S272075","article-title":"Psychometric validation of the EQ-5D-3L in patients with nontuberculous mycobacterial (NTM) lung disease caused by Mycobacterium avium complex (MAC)","volume":"12","author":"Shah","year":"2021","journal-title":"Patient Relat. Outcome Meas."},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1378\/chest.93.3.550","article-title":"Nontuberculous mycobacterial lung disease. Substantiation of a less aggressive approach","volume":"93","author":"Hornick","year":"1988","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.5588\/ijtld.11.0534","article-title":"Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease","volume":"16","author":"Kitada","year":"2012","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000068416","article-title":"Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease","volume":"70","author":"Fujiuchi","year":"2003","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01640-23","article-title":"Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease","volume":"11","author":"Chang","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"10","key":"10.1016\/j.rmed.2025.108052_bib24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1164\/rccm.201807-1243ED","article-title":"Mycobacterium avium complex and bronchiectasis. There's something happening here","volume":"198","author":"Griffith","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib29","article-title":"Obstructive airway disease in patients with treated pulmonary tuberculosis","volume":"103","author":"Snider","year":"1971","journal-title":"Am. Rev. Respir. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/clinids\/3.5.1064","article-title":"Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare","volume":"3","author":"Corpe","year":"1981","journal-title":"Rev. Infect. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2025.108052_bib32","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.124.4.1482","article-title":"Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine","volume":"124","author":"Field","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib33","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/clinids\/3.5.1052","article-title":"Treatment of disease due to Mycobacterium intracellulare","volume":"3","author":"Davidson","year":"1981","journal-title":"Rev. Infect. Dis."},{"issue":"8","key":"10.1016\/j.rmed.2025.108052_bib34","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"Griffith","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib59","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/resp.12287","article-title":"Mycobacterium avium complex infection in non\u2010cystic fibrosis bronchiectasis","volume":"19","author":"Zoumot","year":"2014","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0002-9343(79)90792-7","article-title":"Long-term results of medical treatment in Mycobacterium intracellulare infection","volume":"67","author":"Dutt","year":"1979","journal-title":"Am. J. Med."},{"key":"10.1016\/j.rmed.2025.108052_bib36","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.chest.2023.06.015","article-title":"Microbiological cure at treatment completion is associated with longer survival in patients with Mycobacterium avium complex pulmonary disease","volume":"164","author":"Kim","year":"2023","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5588\/ijtld.11.0148","article-title":"Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease","volume":"16","author":"Ito","year":"2012","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"4","key":"10.1016\/j.rmed.2025.108052_bib37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.resinv.2018.04.002","article-title":"Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease","volume":"56","author":"Naito","year":"2018","journal-title":"Respir Investig"},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.chest.2021.10.048","article-title":"Impact of time between diagnosis and treatment for nontuberculous mycobacterial pulmonary disease on culture conversion and all-cause mortality","volume":"161","author":"Im","year":"2022","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2025.108052_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.chest.2021.02.025","article-title":"Outcomes of inhaled amikacin-containing multidrug regimens for Mycobacterium abscessus pulmonary disease","volume":"160","author":"Kang","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.12111374","article-title":"Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy","volume":"263","author":"Kim","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/ijmy.ijmy_179_17","article-title":"Mycobacterium abscessus subsp. abscessus lung disease: drug susceptibility testing in sputum culture negative conversion","volume":"7","author":"Kobayashi","year":"2018","journal-title":"Int J Mycobacteriol"},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciw723","article-title":"Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense","volume":"64","author":"Park","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcf.2014.07.004","article-title":"Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients","volume":"14","author":"Roux","year":"2015","journal-title":"J. Cyst. Fibros."},{"issue":"7","key":"10.1016\/j.rmed.2025.108052_bib45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/INF.0000000000002274","article-title":"Improved clinical outcome after treatment of Mycobacterium abscessus complex pulmonary disease in children with cystic fibrosis","volume":"38","author":"Chacko","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"7","key":"10.1016\/j.rmed.2025.108052_bib46","doi-asserted-by":"crossref","first-page":"e00011","DOI":"10.1128\/AAC.00011-18","article-title":"Amikacin inhalation as salvage therapy for refractory nontuberculous mycobacterial lung disease","volume":"62","author":"Jhun","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.rmed.2025.108052_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcf.2015.09.007","article-title":"Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis","volume":"15","author":"Qvist","year":"2016","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/archdischild-2021-322177","article-title":"Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study","volume":"107","author":"Saint","year":"2022","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.rmed.2025.108052_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jcf.2017.04.013","article-title":"Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients","volume":"16","author":"DaCosta","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"2","key":"10.1016\/j.rmed.2025.108052_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.chest.2019.03.019","article-title":"Mycobacterium bolletii lung disease in cystic fibrosis","volume":"156","author":"Rollet-Cohen","year":"2019","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2025.108052_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac465","article-title":"Amikacin liposomal inhalation suspension in the treatment of Mycobacterium abscessus lung infection: a French observational experience","volume":"9","author":"Chiron","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/antibiotics11050571","article-title":"Treatment outcome in patients with Mycobacterium abscessus complex lung disease: the impact of tigecycline and amikacin","volume":"11","author":"Yang","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12879-016-1689-6","article-title":"Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series","volume":"16","author":"Namkoong","year":"2016","journal-title":"BMC inf Dis."},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","article-title":"Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmed.2025.108052_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106549","article-title":"Radiographic severity and treatment outcome of Mycobacterium abscessus complex pulmonary disease","volume":"187","author":"Park","year":"2021","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00798-2019","article-title":"Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study","volume":"55","author":"Jhun","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2025.108052_bib57","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12879-018-3113-x","article-title":"High mortality in patients with Mycobacterium avium complex lung disease: a systematic review","volume":"18","author":"Diel","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"suppl_2","key":"10.1016\/j.rmed.2025.108052_bib58","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkx311","article-title":"Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium\u2013intracellulare complex disease","volume":"72","author":"Pasipanodya","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.rmed.2025.108052_bib60","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01636-2018","article-title":"Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease","volume":"53","author":"Moon","year":"2019","journal-title":"Eur. Respir. J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:16:33Z","timestamp":1762337793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":62,"alternative-id":["S0954611125001143"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108052","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between culture conversion and clinical outcomes in nontuberculous mycobacterial pulmonary disease: Narrative review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108052"}}